What's happening
This bill creates new regulations, licensing, and transparency requirements for pharmacy benefit managers in New York State.
Why it matters
Shifts PBMs’ Fiduciary Duty. The bill explicitly requires pharmacy benefit managers (PBMs) to act in the best interest of patients and health plans, making their duty to the covered individual primary in cases of conflict. This is a significant legal shift that may affect how PBMs negotiate prices, manage formularies, and interact with drug manufacturers.
Bans Common Controversial PBM Practices. The legislation prohibits spread pricing (where PBMs retain the difference between what they charge health plans and what they pay pharmacies), prevents PBMs from restricting pharmacists’ ability to inform patients of cheaper alternatives, and bans copayments that exceed the pharmacy’s reimbursement. These provisions could reduce out-of-pocket costs and increase transparency for consumers.
Grants Enforcement and Oversight Powers. By mandating registration and licensing, with penalties for violations, the bill gives state regulators new tools to investigate, audit, and penalize PBMs for unfair practices, conflicts of interest, or deceptive conduct. This oversight could deter anti-competitive behavior and ensure PBMs are accountable to state standards.
Empowers Pharmacies and Patients. Pharmacies gain new rights to appeal PBM reimbursement rates for generic drugs, and both patients and providers are explicitly granted the right to pursue legal remedies if harmed by PBM misconduct. This could level the playing field for independent pharmacies and offer recourse for consumers negatively impacted by PBM practices.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Regulate Pharmacy Benefit Managers
Plain English, a few words. Used as the page title.
Sponsors
History
- Approval memo.166
- Signed chap.828
- Delivered to governor
- Returned to senate
- Passed assembly
- Ordered to third reading rules cal.531
- Substituted for A1396
- Referred to codes
- Delivered to assembly
- Passed senateVote 62–1
- Advanced to third reading
- 2nd report cal.
Show 2 earlier actions
- 1st report cal.543
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Regulate Pharmacy Benefit Managers
Assembly Floor Calendar · Sponsor Richard Gottfried
Full text
12 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
3762
2021-2022 Regular Sessions
IN SENATE
January 30, 2021
Introduced by Sens. BRESLIN, RIVERA, ADDABBO, GAUGHRAN, GOUNARDES, KAMINSKY, KAPLAN, KRUEGER, MAYER, SKOUFIS -- read twice and ordered printed, and when printed to be committed to the Committee on Health
AN ACT to amend the public health law, in relation to pharmacy benefit managers; to amend the insurance law, in relation to registration and licensing of pharmacy benefit managers; and to repeal certain provisions of the public health law relating thereto
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Section 280-a of the public health law is REPEALED and a new section 280-a is added to read as follows:
§ 280-a. Pharmacy benefit managers. 1. Definitions. As used in this section, the following terms shall have the following meanings:
(a) "Health plan or provider" means an entity for which a pharmacy benefit manager provides pharmacy benefit management including, but not limited to: (i) a health benefit plan or other entity that approves, provides, arranges for, or pays for health care items or services, under which prescription drugs for beneficiaries of the entity are purchased or which provides or arranges reimbursement in whole or in part for the purchase of prescription drugs; or (ii) a health care provider or professional that acquires prescription drugs to use or dispense in providing health care to patients where the prescription drug is the subject of the pharmacy benefit manager's pharmacy benefit management services.
(b) "Pharmacy benefit management services" means the service provided to a health plan or provider, directly or through another entity, and regardless of whether the pharmacy benefit manager and the health plan or provider are related, or associated by ownership, common ownership, organization or otherwise; including the procurement of prescription drugs to be dispensed to patients, or the administration or management
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD00570-01-1
S. 3762 2
of prescription drug benefits, including but not limited to, any of the following:
(i) mail service pharmacy;
(ii) claims processing, retail network management, or payment of claims to pharmacies for dispensing prescription drugs;
(iii) clinical or other formulary or preferred drug list development or management;
(iv) negotiation or administration of rebates, discounts, payment differentials, or other incentives, for the inclusion of particular prescription drugs in a particular category or to promote the purchase of particular prescription drugs;
(v) patient compliance, therapeutic intervention, or generic substitution programs;
(vi) disease management;
(vii) drug utilization review or prior authorization;
(viii) adjudication of appeals or grievances related to prescription drug coverage;
(ix) contracting with network pharmacies; and
(x) controlling the cost of covered prescription drugs.
(c) "Pharmacy benefit manager" means any entity that performs pharmacy benefit management services for a health plan or provider.
(d) "Maximum allowable cost price" means a maximum reimbursement amount set by the pharmacy benefit manager for therapeutically equivalent multiple source generic drugs.
(e) "Controlling person" means any person or other entity who or which directly or indirectly has the power to direct or cause to be directed the management, control or activities of a pharmacy benefit manager.
(f) "Covered individual" means a member, participant, enrollee, contract holder or policy holder or beneficiary of a health plan or provider.
(g) "License" means a license to be a pharmacy benefit manager, under article twenty-nine of the insurance law.
(h) "Spread pricing" means the practice of a pharmacy benefit manager retaining an additional amount of money in addition to the amount paid to the pharmacy to fill a prescription.
(i) "Superintendent" means the superintendent of financial services.
2. Duty, accountability and transparency. (a) The pharmacy benefit manager shall have a duty and obligation to the covered individual and the health plan or provider, and shall perform pharmacy benefit management services with care, skill, prudence, diligence, and professionalism, and for the best interests of the covered individual, and the health plan or provider. Where there is a conflict in the pharmacy benefit manager's duty or obligation under this paragraph to the covered individual and any other party, the duty or obligation to the covered individual shall be primary.
(b) All funds received by the pharmacy benefit manager in relation to providing pharmacy benefit management services shall be received by the pharmacy benefit manager in trust for the health plan or provider and shall be used or distributed only pursuant to the pharmacy benefit manager's contract with the health plan or provider or applicable law; including any administrative fee or payment to the pharmacy benefit manager expressly provided for in the contract to compensate the pharmacy benefit manager for its services. Any funds received by the pharmacy benefit manager through spread pricing shall be subject to this paragraph.
S. 3762 3
(c) The pharmacy benefit manager shall account, annually or more frequently to the health plan or provider for any pricing discounts, rebates of any kind, inflationary payments, credits, clawbacks, fees, grants, chargebacks, reimbursements, or other benefits received by the pharmacy benefit manager. The pharmacy benefit manager shall ensure that any portion of such income, payments, and financial benefits is passed through to the health plan or provider in full to reduce the reportable ingredient cost. The health plan or provider shall have access to all financial and utilization information of the pharmacy benefit manager in relation to pharmacy benefit management services provided to the health plan or provider.
(d) The pharmacy benefit manager shall disclose in writing to the health plan or provider the terms and conditions of any contract or arrangement between the pharmacy benefit manager and any party relating to pharmacy benefit management services provided to the health plan or provider including but not limited to, dispensing fees paid to the pharmacies.
(e) The pharmacy benefit manager shall disclose in writing to the health plan or provider any activity, policy, practice, contract or arrangement of the pharmacy benefit manager that directly or indirectly presents any conflict of interest with the pharmacy benefit manager's relationship with or obligation to the health plan or provider.
(f) Any information required to be disclosed by a pharmacy benefit manager to a health plan or provider under this section that is reasonably designated by the pharmacy benefit manager as proprietary or trade secret information shall be kept confidential by the health plan or provider, except as required or permitted by law, including disclosure necessary to prosecute or defend any legitimate legal claim or cause of action.
(g) The superintendent, in consultation with the commissioner:
(i) may make regulations defining, limiting, and relating to the duties, obligations, requirements and other provisions relating to pharmacy benefit managers under this subdivision; and
(ii) shall establish, by regulation, minimum standards for pharmacy benefit management services which shall address the elimination of: conflicts of interest between pharmacy benefit managers and covered individuals, health benefit plans and health care providers; spread pricing; and deceptive practices, anti-competitive practices, and unfair claims practices.
(h) A health care provider and a covered individual shall be deemed to be third-party beneficiaries of the duties, obligations and requirements applicable to the pharmacy benefit manager under this section and shall be entitled to legal or equitable relief for any injury or loss to the health care provider or the covered individual caused by any violation of such duties, obligations or requirements.
3. Prescriptions. A pharmacy benefit manager may not substitute or cause the substituting of one prescription drug for another in dispensing a prescription, or alter or cause the altering of the terms of a prescription, except with the approval of the prescriber or as explicitly required or permitted by law.
4. Appeals. A pharmacy benefit manager shall, with respect to contracts between a pharmacy benefit manager and a pharmacy or, alternatively, a pharmacy benefit manager and a pharmacy's contracting agent, such as a pharmacy services administrative organization, include a reasonable process to appeal, investigate and resolve disputes regarding
S. 3762 4
multi-source generic drug pricing. The appeals process shall include the following provisions:
(a) the right to appeal by the pharmacy and/or the pharmacy's contracting agent shall be limited to thirty days following the initial claim submitted for payment;
(b) a telephone number through which a network pharmacy may contact the pharmacy benefit manager for the purpose of filing an appeal and an electronic mail address of the individual who is responsible for processing appeals;
(c) the pharmacy benefit manager shall send an electronic mail message acknowledging receipt of the appeal. The pharmacy benefit manager shall respond in an electronic message to the pharmacy and/or the pharmacy's contracting agent filing the appeal within seven business days indicating its determination. If the appeal is determined to be valid, the maximum allowable cost for the drug shall be adjusted for the appealing pharmacy effective as of the date of the original claim for payment. The pharmacy benefit manager shall require the appealing pharmacy to reverse and rebill the claim in question in order to obtain the corrected reimbursement;
(d) if an update to the maximum allowable cost is warranted, the pharmacy benefit manager or covered entity shall adjust the maximum allowable cost of the drug effective for all similarly situated pharmacies in its network in the state on the date the appeal was determined to be valid; and
(e) if an appeal is denied, the pharmacy benefit manager shall identify the national drug code of a therapeutically equivalent drug, as determined by the federal Food and Drug Administration, that is available for purchase by pharmacies in this state from wholesalers registered pursuant to subdivision four of section sixty-eight hundred eight of the education law at a price which is equal to or less than the maximum allowable cost for that drug as determined by the pharmacy benefit manager.
5. Contract provisions. No pharmacy benefit manager shall, with respect to contracts between such pharmacy benefit manager and a pharmacy or, alternatively, such pharmacy benefit manager and a pharmacy's contracting agent, such as a pharmacy services administrative organization:
(a) prohibit or penalize a pharmacist or pharmacy from disclosing to an individual purchasing a prescription medication information regarding:
(i) the cost of the prescription medication to the individual, or
(ii) the availability of any therapeutically equivalent alternative medications or alternative methods of purchasing the prescription medication, including but not limited to, paying a cash price;
(b) charge or collect from an individual a copayment that exceeds the total submitted charges by the pharmacy for which the pharmacy is paid. If an individual pays a copayment, the pharmacy shall retain the adjudicated costs and the pharmacy benefit manager shall not redact or recoup the adjudicated cost; or
(c) require a pharmacy to meet any pharmacy accreditation standard or recertification requirement inconsistent with, more stringent than, or in addition to federal and state requirements for licensure as a pharmacy.
§ 2. The insurance law is amended by adding a new article 29 to read as follows:
S. 3762 5
ARTICLE 29
PHARMACY BENEFIT MANAGERS Section 2901. Definitions.
2902. Acting without a registration.
2903. Registration requirements for pharmacy benefit managers.
2904. Reporting requirements for pharmacy benefit managers.
2905. Acting without a license.
2906. Licensing of a pharmacy benefit manager.
2907. Revocation or suspension of a registration or license of a
pharmacy benefit manager.
2908. Penalties for violations.
2909. Stay or suspension of superintendent's determination.
2910. Revoked registrations or licenses.
2911. Change of address.
2912. Applicability of other laws.
2913. Assessments.
§ 2901. Definitions. For purposes of this article:
(a) "Controlling person" is any person or other entity who or which directly or indirectly has the power to direct or cause to be directed the management, control or activities of a pharmacy benefit manager.
(b) The terms "covered individual", "health plan or provider", "pharmacy benefit manager" and "pharmacy benefit management services" have the same meanings as defined by section two hundred eighty-a of the public health law.
§ 2902. Acting without a registration. (a) No person, firm, association, corporation or other entity may act as a pharmacy benefit manager on or after April first, two thousand twenty-one and prior to January first, two thousand twenty-three, without having a valid registration as a pharmacy benefit manager filed with the superintendent in accordance with this article and any regulations promulgated thereunder.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the public health law, in relation to pharmacy benefit managers; to amend the insurance law, in relation to registration and licensing of pharmacy benefit managers; and to repeal certain provisions of the public health law relating thereto
Purpose or general idea of bill
This bill requires licensure for pharmacy benefit managers (Pails) and specifies their duties and obligations as service providers.
Summary of specific provisions
Section 1 of the bill amends Public Health Law 6 280-a to define the range of activities pharmacy benefit managers (PBM) engage in. A new subdivision 2 provides that PBMs have a duty to the covered individual and the health plan or provider to perform pharmacy benefit management services with care, skill, prudence, diligence, and professionalism, and for the best interests primarily of the covered individual, and the health plan or provider and require full disclosure to health plans and providers with whom they contract. A new subdivision 3 bars the substi- tution of prescribed drugs. Subdivision 4 is current subdivision 2 renumbered, and subdivision 5 renumbers a provision that was added as part of the 2018 state budget.
Read the full memo (623 words)
Section 2 of the bill enacts and new Article 29 in the Insurance Law to require all. PBMs doing business in New York to register with the Super- intendent of Insurance for the 2020 calendar year, and after 2022, to be licensed, renewable every three years. The Superintendent, in consulta- tion with the Commissioner of Health will establish minimum standards for the issuance of a PEN license, addressing conflicts of interest, deceptive practices, anti-competitive practices, unfair claims practices and protection of consumers.
Grounds for Revocation or suspension of a registration or license include fraudulent applications or practices, incompetence, financial irresponsibility, intentional misrepresentation , unfair trade practice and fraud, violation of Superintendent standards as well as disciplinary actions in other states. Due process addressing notice, appearance, evidence and appeal are provided.
Section 3 of the bill adds violation of the new Article 29 to declared violations of the Insurance Law.
Section 4 of the bill is a severability clause allowing that if any provision of the law is determined by a court to be invalid,. that determination will not affect the validity of the rest of the Act.
Justification
PBMs are companies that manage prescription drug benefit programs for health plans. PBMs promote themselves as saving health. plans and their covered members money, but in reality, their negotiations and the discounts or rebates they get from drug companies are very secretive. PBMs commonly pocket payments from drug manufacturers that ought to be used to lower drug prices, and they accept payments in exchange for giving preference to more expensive drugs. The common practice known as spread-pricing enables the PBMs to charge pharmacists higher prices than the PBM is paying to manufacturers, yielding additional unknown profits.
This bill would require that PBMs be licensed by the Insurance Depart- ment and conform to standards established by the Insurance and Health Departments. It will require disclosure to the plans with whom they contract, and to the Department. of all possible revenue streams and the terms and conditions that they place on their networks of pharmacies. In 2019 this bill passed almost unanimously but was vetoed last year. This new bill includes some helpful technical changes that had been proposed by the Governor in chapter amendment discussions.
This bill opens the "black box" as PBMs are often called, to require accountability, transparency and fair dealing of all PBMs serving New York residents.
Prior legislative history
2017-2018: A.10985 - referred to Health
2019: S.6531 / A.2836 - veto 286
2020: 3.7828
Fiscal implications
None
Effective date
Ninetieth days after it shall become law.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.